The LIPOSORBER team will be in Philadelphia on Nov 2-5 for ASN's Kidney Week Annual Meeting. Make sure to stop by our booth (506) to learn about how treatment with LIPOSORBER has enabled nearly 50% of steroid-resistant primary FSGS patients to attain complete or partial remission.* Ref: Muso, Eri et al. “Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.” Clinical and experimental nephrology vol. 19,3 (2015): 379-86. doi:10.1007/s10157-014-0996-8. *Serum lipid levels and outcomes in each treatment group were compared after approximately 6 years. Based on study that took place over two (2) years. #ASN2023 #kidneywk
Kaneka Medical America (KMA) - LIPOSORBER’s Post
More Relevant Posts
-
We are pleased to share that the American Heart Association (AHA) has officially published a Scientific Statement on Lipoprotein Apheresis. You can read the article here: https://buff.ly/3U36393 #americanheartassociation #aha2024 #liposorber #LipoproteinApheresis
To view or add a comment, sign in
-
Check out Family Heart's recent announcement about the launch of Cholesterol Connect and the new LDL Safe Zone website! @FamilyHeartFdn
To view or add a comment, sign in
-
As we come to a close of this month, we would like to thank all of our apheresis nurses who make a difference in the lives of patients who rely on apheresis treatments. Your dedication, compassion, and expertise are truly invaluable. Thank you for all that you do!
To view or add a comment, sign in
-
PAD is more common in women and typically diagnosed in patients 60 and older. #PADawarenessmonth #peripheralarterydisease
To view or add a comment, sign in
-
Stay informed, stay empowered. Today is FH awareness day and we're proud to support those living with familial hypercholesterolemia. Together, we can make a difference in managing this genetic condition. #FHawareness #LIPOSORBER
To view or add a comment, sign in
-
PAD causes over 1/3 of patients have pain, functional impairment and mobility loss, causing a reduced quality of life. #PADAwarenessMonth #peripheralarterydisease
To view or add a comment, sign in
-
The #LIPOSORBER team will be in Dallas on Sunday for Family Heart's annual Global Summit - the only conference solely dedicated to aligning stakeholders and catalyzing solutions to reduce the burden of CVD in people with inherited lipid disorders, including FH and elevated Lp(a). #familyheart #familyheartsummit
To view or add a comment, sign in
-
Join leading experts this Friday for AHA's CME webinar as they address comprehensive clinical recommendations for managing patients with elevated Lp(a) and PAD. Register here: https://buff.ly/3XGvf7l
To view or add a comment, sign in
-
Did you know that atherosclerosis is one of the leading causes of PAD? #PADAwarenessMonth #peripheralarterydisease
To view or add a comment, sign in
-
This month sheds a much-needed spotlight on the importance of early detection of peripheral artery disease (PAD). Here are some ways we can come together to provide hope and advocate for awareness of PAD. #PADawareness #peripheralarterydisease
To view or add a comment, sign in
72 followers